Search

everythinglearnresearchcommunity

for

Search:↓

A Doberman Pinscher had a rare form of autoimmune disease causing hair loss and other severe symptoms.

Baricitinib is more effective than tofacitinib for hair regrowth in alopecia patients.

DN106212, an extract from a plant, is better at promoting hair growth than other tested substances by affecting hair growth factors and follicle development.

Scarring alopecia, a type of hair loss, is most common in females under 35, often caused by discoid lupus erythematosus and pseudopelade of Brocq. Skin punch biopsy and histopathology are key to identifying its cause.

Trichoscopy is a reliable method for diagnosing hair and scalp disorders quickly and non-invasively.

The symposium highlighted the importance of genetics in understanding and treating complex skin diseases.

Dermoscopy helps diagnose and differentiate various hair and scalp conditions.

New digital tools are improving the diagnosis and understanding of irreversible hair loss conditions.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

In vivo reflectance confocal microscopy is useful for evaluating hair shaft diseases but needs improvement for deeper hair follicle issues.

The immune processes causing VKH and vitiligo are similar in dogs and humans.

Abrocitinib may effectively treat stubborn alopecia universalis.

Ruxolitinib can cause a delayed skin reaction on the nose.

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

Griseofulvin effectively treats tinea capitis in infants.

COVID-19 can lead to different skin symptoms and might trigger autoimmune diseases in genetically susceptible people.

The DNA convention was a valuable opportunity for learning and networking, especially after COVID-19.

Blocking certain pathways with kinase inhibitors may help treat cutaneous lupus erythematosus.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

Regulatory T cells help heal skin and grow hair, and their absence can lead to healing issues and hair loss.

Mitochondrial dysfunction is linked to various skin conditions and could be a target for treatments.

Stress may trigger hair loss by affecting immune protection in hair follicles.

About 12% of children in Kota, Rajasthan, experience hair loss, mainly due to fungal infections, with early treatment advised to prevent worsening.

COVID-19 mRNA vaccines may increase the risk of flare-ups in certain inflammatory diseases.

Trichoscopy is a quick and reliable way to diagnose hair loss in women.

Higher CRHR1 levels in AA patients lead to increased inflammation.

People with hair loss conditions may also have thyroid disorders, but more research is needed to understand the connection.

Lifestyle changes during the early COVID-19 outbreak led to more cases of acne and other skin conditions, but fewer cases of rosacea and skin infections.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.